GENETIC AND EPIGENETIC MECHANISMS IN THE PATHOGENESIS OF NEUROFIBROMATOSIS TYPE-I

被引:27
|
作者
METHENY, LJ
CAPPIONE, AJ
SKUSE, GR
机构
[1] UNIV ROCHESTER,MED CTR,DEPT MED,DIV GENET,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,SCH MED & DENT,CTR CANC,ROCHESTER,NY 14642
关键词
EPIGENETIC GTPASE ACTIVATING PROTEIN; NERVOUS SYSTEM TUMORS; NEUROFIBROMATOSIS; PATHOGENESIS; POSTTRANSCRIPTIONAL MODIFICATION; TUMOR SUPPRESSOR;
D O I
10.1097/00005072-199511000-00001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibromatosis type I (NF1) is a common genetic disease which leads to a variety of clinical features affecting cells of neural crest origin. In the period since the NF1 gene was isolated in 1991, our understanding of the genetics of NF1 has increased remarkably. One of the most striking aspects of NF1 genetics is its complexity, both in terms of gene organization and expression. The gene is large and, when mutated, gives rise to diverse manifestations. A growing body of data suggests that mutations in the NF1 gene alone may not be responsible for all of the features of this disease. Epigenetic mechanisms, those which affect the NF1 transcript, play a role in the normal expression of the NF1 gene. Therefore, aberrations in those epigenetic processes are most likely pathogenic. Herein we summarize salient aspects of the vast body of NF1 literature and provide some insights into the myriad of regulatory mechanisms that may go awry in the genesis of this common but complex disease.
引用
收藏
页码:753 / 760
页数:8
相关论文
共 50 条
  • [1] HLA SYSTEM AND NEUROFIBROMATOSIS, TYPE-I
    PERIS, VT
    SORIANO, XR
    RUIZ, DS
    ANDREU, RM
    [J]. ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1989, 64 (07): : 588 - 590
  • [2] CUTANEOUS SYMPTOMS OF NEUROFIBROMATOSIS TYPE-I
    CLAUDY, A
    [J]. ARCHIVES DE PEDIATRIE, 1995, 2 : S79 - S80
  • [3] JUVENILE XANTHOGRANULOMA IN NEUROFIBROMATOSIS TYPE-I
    SMITT, JHS
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1991, 125 (04) : 390 - 390
  • [4] PATHOGENESIS OF TYPE-I DIABETES
    VENTO, S
    GAROFANO, T
    [J]. LANCET, 1988, 2 (8621): : 1200 - 1200
  • [5] MOLECULAR-GENETICS OF NEUROFIBROMATOSIS TYPE-I
    VIDAUD, D
    [J]. ARCHIVES DE PEDIATRIE, 1995, 2 : S80 - S81
  • [6] ORAL NEUROFIBROSARCOMA ASSOCIATED WITH NEUROFIBROMATOSIS TYPE-I
    NEVILLE, BW
    HANN, J
    NARANG, R
    GAREN, P
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1991, 72 (04): : 456 - 461
  • [7] NEUROFIBROMATOSIS CELLS SYNTHESIZE TYPE-I COLLAGEN
    PENTTINEN, R
    MARTTALA, T
    HOLLMEN, T
    [J]. UPSALA JOURNAL OF MEDICAL SCIENCES, 1977, 82 (02) : 149 - 149
  • [8] GENETIC-LINKAGE MAPPING OF CHROMOSOME-17 MARKERS AND NEUROFIBROMATOSIS TYPE-I
    VANCE, JM
    PERICAKVANCE, MA
    YAMAOKA, LH
    SPEER, MC
    ROSENWASSER, GOD
    SMALL, K
    GASKELL, PC
    HUNG, WY
    ALBERTS, MJ
    HAYNES, CS
    GILBERT, JR
    AYLSWORTH, AS
    ROSES, AD
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1989, 44 (01) : 25 - 29
  • [9] ORAL MANIFESTATIONS OF NEUROFIBROMATOSIS TYPE-I AND TYPE-II
    GEIST, JR
    GANDER, DL
    STEFANAC, SJ
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1992, 73 (03): : 376 - 382
  • [10] Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
    Brems, Hilde
    Beert, Eline
    de Ravel, Thomy
    Legius, Eric
    [J]. LANCET ONCOLOGY, 2009, 10 (05): : 508 - 515